Literature DB >> 22795817

Epidemic of iron overload in dialysis population caused by intravenous iron products: a plea for moderation.

Nosratola D Vaziri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22795817     DOI： 10.1016/j.amjmed.2012.02.009

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  16 in total

1.  Iron sucrose impairs phagocytic function and promotes apoptosis in polymorphonuclear leukocytes.

Authors:  Hirohito Ichii; Yuichi Masuda; Tania Hassanzadeh; Mateen Saffarian; Sastry Gollapudi; Nosratola D Vaziri
Journal:  Am J Nephrol       Date:  2012-06-19       Impact factor: 3.754

2.  The Value of Intravenous Iron: Beyond the Cave of Speculation.

Authors:  Daniel W Coyne; Steven Fishbane
Journal:  J Am Soc Nephrol       Date:  2020-04-06       Impact factor: 10.121

3.  The comparative short-term effectiveness of iron dosing and formulations in US hemodialysis patients.

Authors:  Abhijit V Kshirsagar; Janet K Freburger; Alan R Ellis; Lily Wang; Wolfgang C Winkelmayer; M Alan Brookhart
Journal:  Am J Med       Date:  2013-04-15       Impact factor: 4.965

4.  Reassessment of Iron Biomarkers for Prediction of Dialysis Iron Overload: An MRI Study.

Authors:  Guy Rostoker; Mireille Griuncelli; Christelle Loridon; Théophile Magna; Gabrielle Machado; Gilles Drahi; Hervé Dahan; Philippe Janklewicz; Yves Cohen
Journal:  PLoS One       Date:  2015-07-16       Impact factor: 3.240

5.  Maximal standard dose of parenteral iron for hemodialysis patients: an MRI-based decision tree learning analysis.

Authors:  Guy Rostoker; Mireille Griuncelli; Christelle Loridon; Théophile Magna; Philippe Janklewicz; Gilles Drahi; Hervé Dahan; Yves Cohen
Journal:  PLoS One       Date:  2014-12-15       Impact factor: 3.240

6.  Comparison of short-term efficacy of iron sucrose with those of ferric chloride in hemodialysis patients: An open-label study.

Authors:  Po-Jen Hsiao; Jenq-Shyong Chan; Kun-Lin Wu; Wen-Fang Chiang; Jing-Shu Huang; Chia-Chao Wu; Pauling Chu; Jin-Shuen Chen
Journal:  J Res Med Sci       Date:  2016-11-02       Impact factor: 1.852

Review 7.  Practical considerations for iron therapy in the management of anaemia in patients with chronic kidney disease.

Authors:  Simon D Roger
Journal:  Clin Kidney J       Date:  2017-11-28

8.  At pharmacologically relevant concentrations intravenous iron preparations cause pancreatic beta cell death.

Authors:  Yuichi Masuda; Hirohito Ichii; Nosratola D Vaziri
Journal:  Am J Transl Res       Date:  2013-12-01       Impact factor: 4.060

9.  Intravenous iron supplementation practices and short-term risk of cardiovascular events in hemodialysis patients.

Authors:  Abhijit V Kshirsagar; Janet K Freburger; Alan R Ellis; Lily Wang; Wolfgang C Winkelmayer; M Alan Brookhart
Journal:  PLoS One       Date:  2013-11-01       Impact factor: 3.240

Review 10.  Iatrogenic Iron Overload in Dialysis Patients at the Beginning of the 21st Century.

Authors:  Guy Rostoker; Nosratola D Vaziri; Steven Fishbane
Journal:  Drugs       Date:  2016-05       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.